Transplantation of induced pluripotent stem cell-derived neurospheres for peripheral nerve repair

https://doi.org/10.1016/j.bbrc.2012.01.154Get rights and content

Abstract

In spite of the extensive research using induced pluripotent stem (iPS) cells, the therapeutic potential of iPS cells in the treatment of peripheral nerve injury is largely unknown. In this study, we repaired peripheral nerve gaps in mice using tissue-engineered bioabsorbable nerve conduits coated with iPS cell-derived neurospheres. The secondary neurospheres derived from mouse iPS cells were suspended in each conduit (4000,000 cells per conduit) and cultured in the conduit in three-dimensional (3D) culture for 14 days. We then implanted them in the mouse sciatic nerve gaps (5 mm) (iPS group; n = 10). The nerve conduit alone was implanted in the control group (n = 10). After 4, 8 and 12 weeks, motor and sensory functional recovery in mice were significantly better in the iPS group. At 12 weeks, all the nerve conduits remained structurally stable without any collapse and histological analysis indicated axonal regeneration in the nerve conduits of both groups. However, the iPS group showed significantly more vigorous axonal regeneration. The bioabsorbable nerve conduits created by 3D-culture of iPS cell-derived neurospheres promoted regeneration of peripheral nerves and functional recovery in vivo. The combination of iPS cell technology and bioabsorbable nerve conduits shows potential as a future tool for the treatment of peripheral nerve defects.

Highlights

► This is the first report to use iPS cells to reconstruct a defected peripheral nerve. ► The nerve conduits coated with iPS cell-derived neurospheres were used for repair. ► iPS cell-derived neurospheres promoted regeneration of peripheral nerves. ► The combination of iPS cells and nerve conduits could represent a future tool.

Introduction

Recently, there have been great advancements in the study of induced pluripotent stem cells (iPS) cells in the field of regenerative medicine [1], [2]. The iPS cells have the ability to differentiate into various types of somatic cells, such as cardiomyocytes, hepatic cells, and pancreatic cells, and thus have been used for understanding the mechanisms of diseases, development of new drugs, and for regenerative therapy including cell implantation [3], [4], [5], [6], [7]. Recently, methods for neural induction of iPS cells have been established by Okada and Miura [8], [9]. In these studies, iPS cells were differentiated into neural precursor cell aggregates, so called neurospheres, which are then able to differentiate into neurons and glial cells. By application of the same method of neural induction of iPS cells for the regenerative therapy of the central nervous system, Nakamura et al. confirmed that grafted human-iPS-cell-derived neurospheres promoted motor functional recovery after spinal cord injury in mice [10], [11], [12]. However, there have been few reports of the application of iPS cells for regenerative therapy of peripheral nerves. The purpose of this study was to repair sciatic nerve gaps in mice using bioabsorbable nerve conduits coated with iPS cell-derived neurospheres, utilizing the neural induction of iPS cells for peripheral nerve regeneration.

Section snippets

Neural induction of iPS cells

We used mouse iPS cells of the iPS-MEF-Ng-178B-5 cell line that was established using three transcription factors, Oct3/4, Sox2 and Klf4. iPS cells were provided by RIKEN BRC through the National Bio-Resource Project of MEXT, Japan [13]. iPS cells were cultured as previously described [1], [2]. For neural induction, we generated neurospheres containing neural stem/progenitor cells from the iPS cells using a published method [8], [9]. After embryoid body formation, iPS cells formed primary

The nerve conduits coated with iPS cell-derived neurospheres

The iPS cell-derived secondary neurospheres were adhered to the inner surface of the nerve conduits and had migrated into the inner porous sponge in the HE-stained images (Fig. 1D). The iPS cell-derived neurospheres could be grafted onto the nerve conduits and three-dimensional (3D)-cultured in the nerve conduits as a scaffold.

Functional analysis

The recovery of motor function was assessed by walking track analysis. The mean values of the PLF in the iPS group were significantly lower than in the control group at

Discussion

There have been a few studies reporting the application of stem cells such as adipose-derived stem cells, hair follicle stem cells, bone marrow mesenchymal stem cells and ES cells to the regeneration of peripheral nerves using tissue engineered nerve conduits [20], [21], [22], [23], [24], [25], [26]. However, few reports have used a combination of iPS cells with nerve conduits to promote the re-growth of peripheral nerves. Wang et al. described tissue engineered nerve conduits fabricated by

Acknowledgments

This work was supported in part by a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Project Grant No. 21591904).

The authors thank Shinya Yamanaka (Center for iPS Cell Research and Application, Kyoto University, Japan) and Kyoko Miura (Department of Physiology, School of Medicine, Keio University, Japan) for their excellent technical assistance with cell culture and neural induction of iPS cell and Kanako Hata

References (32)

  • J. Hanna et al.

    Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

    Science

    (2007)
  • D. Xu et al.

    Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

    Proc. Natl. Acad. Sci. USA

    (2009)
  • Y. Yoshida et al.

    Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration

    Circulation

    (2010)
  • K. Okita et al.

    Induced pluripotent stem cells: opportunities and challenges

    Philos. Trans. R Soc. Lond. B Biol. Sci.

    (2011)
  • Y. Okada et al.

    Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells

    Stem Cells

    (2008)
  • K. Miura et al.

    Variation in the safety of induced pluripotent stem cell lines

    Nat. Biotechnol.

    (2009)
  • Cited by (62)

    • Long-term survival of transplanted induced pluripotent stem cell-derived neurospheres with nerve conduit into sciatic nerve defects in immunosuppressed mice

      2021, Biochemistry and Biophysics Reports
      Citation Excerpt :

      Clinical trials using iPSC-based cell transplantation therapy are currently underway in various fields of regenerative medicine [3–5]. In previous studies, we investigated iPSC-based therapeutic approaches for peripheral nerve regeneration and demonstrated the efficacy and safety of the transplantation of iPSCs with tissue-engineered bioabsorbable nerve conduits [6–10]. In particular, we found that the transplantation of mouse iPSC-derived neurospheres containing neural stem/progenitor cells, with nerve conduits promoted nerve regeneration in the long term in murine sciatic nerve defect models [8].

    • Matrices, scaffolds & carriers for cell delivery in nerve regeneration

      2019, Experimental Neurology
      Citation Excerpt :

      PCL is also a poly(α-hydroxyester), obtained by ring opening polymerization of ε-caprolactone. Uemura et al. used iPSC-derived neurospheres-seeded PLA/PCL conduits to bridge a 5mm sciatic nerve gap in mouse (Uemura et al., 2012). Walking track analysis relative to un-operated side and foot withdrawal from hot water showed improvements in motor and sensory function, respectively, with cell-seeded conduits compared to acellular conduits from 4 weeks to 12 weeks post-injury.

    View all citing articles on Scopus
    View full text